Markedly increased risk of myeloid neoplasia among clonal hematopoiesis carriers with multiple TET2 mutations
Blood Advances
· Elsevier
Аннотация
Publication date: 24 November 2026 Source: Blood Advances, Volume 10, Issue 22 Author(s): Fabio A. Schwandt, Jake Tobin, Shreyashee Mallik, Rithin Nedumannil, Julian Ronnacker, William G. Dunn, Veselin Manojlovic, Pedro M. Quiros, Sean Wen, Malgorzata Gozdecka, Margarete A. Fabre, Muxin Gu, George S. Vassiliou
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Гематология»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Markedly increased risk of myeloid neoplasia among clonal hematopoiesis carriers with multiple TET2 mutations. // Blood Advances. – URL: https://www.sciencedirect.com/science/article/pii/S2473952926006610?dgcid=rss_sd_all
Markedly increased risk of myeloid neoplasia among clonal hematopoiesis carriers with multiple TET2 mutations. Blood Advances. https://www.sciencedirect.com/science/article/pii/S2473952926006610?dgcid=rss_sd_all
“Markedly increased risk of myeloid neoplasia among clonal hematopoiesis carriers with multiple TET2 mutations.” Blood Advances.
@article{article38111,
title = {Markedly increased risk of myeloid neoplasia among clonal hematopoiesis carriers with multiple TET2 mutations},
journal = {Blood Advances},
url = {https://www.sciencedirect.com/science/article/pii/S2473952926006610?dgcid=rss_sd_all}
}